You are here: Home › Resource Center for Research › Funding Opportunity Announcements › Cutting-Edge Basic Research Awards (CEBRA) (R21): PAR-12-086

Cutting-Edge Basic Research Awards (CEBRA) (R21): PAR-12-086

http://grants.nih.gov/grants/guide/pa-files/PAR-12-086.html

FOA Purpose: The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to drug abuse and addiction and how to prevent and treat them. It supports research that is high-risk and potentially high-impact that is underrepresented or not included in NIDA's current portfolio. The proposed research should: (1) test a highly novel and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would have a substantial impact on current thinking; and/or (2) develop or adapt innovative techniques or methods for addiction research, or that have promising future applicability to drug abuse research.

Letter of Intent Due Date: Not Applicable.

Application Due Date(s): August 20, 2012; December 20, 2012; August 20, 2013, December 20, 2013, August 20, 2014, and December 19, 2014, by 5:00 PM local time of applicant organization.

Expiration Date: December 20, 2014

Funding

The project is supported by grant 8U54MD007587-03 (RCMI Clinical and Translational Research award, University of Puerto Rico Medical Sciences Campus) from the National Institute on Minority Health and Health Disparities (NIMHD), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIMHD or NIH.

Consortium Institutions

The Puerto Rico Clinical and Translational Research Consortium is a collaborative project of the the University of Puerto Rico Medical Sciences Campus, Universidad Central del Caribe and Ponce School of Medicine and Health Sciences.